A portal graph can connect any two numbers that share a label. That does not guarantee the points represent the same quantity, specimen, method, or unit. Before interpreting a rise or fall, build the series from the original reports and mark where comparability becomes uncertain.
CDC's standardization programs exist because comparable clinical measurements require sustained technical work. Some biomarkers have strong reference systems; others are harmonized to agreed procedures, and comparability can still depend on the assay. A clean graph is a display choice, not proof that every underlying result is interchangeable.
Start with identity, then ask about change
The first question is whether the reports describe the same analyte and kind of result. Similar names can refer to total and free forms, activity and concentration, calculated and directly measured values, or different specimen sources. A method-specific comment may be essential to interpreting the label.
Preserve these fields for each point:
| Field | Why it belongs in the trend record |
|---|---|
| Test and component name | Prevents combining related but distinct measurements |
| Specimen | Blood, urine, and other sources may answer different questions |
| Result and units | A number has no scale without its unit |
| Reference or decision information | Shows what accompanied that exact result |
| Performing laboratory | Identifies where method questions can be directed |
| Method or platform, when reported | Marks a possible change in measurement system |
| Collection date and context | Keeps biological timing beside the value |
| Report status | Separates preliminary, final, and corrected results |
An identity check is a gate. If two points are different quantities, converting the typography cannot make them the same measurement. If identity is uncertain, ask the laboratory or responsible healthcare professional before calculating a trend.
Also confirm that each point is the version you mean to compare. The guide to preliminary, final, and corrected lab reports explains why report status and correction history should travel with the number.
Units can change the digits without changing the quantity
Suppose an invented concentration is reported as 12 milligrams per deciliter on one report and 120 milligrams per liter on another. Because one liter contains ten deciliters, those two values express the same mass concentration. Treating 120 as a tenfold biological rise would be a unit error.
The conversion works because the numerator and measured substance are the same and only the volume unit changed. It cannot be generalized blindly. A mass concentration such as milligrams per liter and an amount-of-substance concentration such as micromoles per liter relate through the substance's molar mass and the exact analyte definition.
NIST's SI guide distinguishes forms of concentration and their units. Do not use a generic online converter without confirming that it applies to the exact quantity. Preserve the original result and conversion rule even when a healthcare system displays a converted value.
Percentage, ratio, index, and categorical results need their own care. A result expressed as a percentage cannot be converted to an absolute concentration merely because both use numbers. “Detected” and “not detected” do not form a numeric slope at all.
Recalculate only when the relationship is valid
If a valid unit conversion is needed for viewing, keep two columns: the value exactly as reported and the converted display value. State the conversion source and check the arithmetic. This protects the original record if an assumption later proves wrong.
For the fictional mass-concentration example:
12 mg/dL × 10 dL/L = 120 mg/L
The units cancel visibly. That dimensional check is useful. Yet it confirms only the conversion, not whether the specimens, methods, or clinical contexts match.
Avoid rounding before the final display. Repeated conversion and rounding can create a small artificial change. Do not add decimal places the source measurement did not report; extra digits can suggest precision that the original result did not contain.
A method change can create a break in the line
Laboratories may change instruments, reagents, calibration, calculations, or reporting conventions. A report may name the method or include a note that comparison with previous methods needs caution. Preserve those notes rather than copying only the result.
CDC distinguishes standardization from harmonization and explains that both pursue comparability. That effort applies to selected measurements under defined systems. Do not assume that every test with a standardized-looking name yields interchangeable values from every technology.
When a method changes, mark the date on the trend. The healthcare professional may still find the series useful, may interpret change with caution, or may establish a new baseline. General education cannot decide which response fits a particular analyte and clinical question.
The reference interval can also change at the method break. A value can carry a different flag even when its number changes little. That does not prove the person's biology crossed a universal boundary; it can reflect a different interval, unit, method, or applicable population.
The separate explainer on why laboratory reference intervals vary describes what an interval represents. For a trend audit, preserve each report's own interval instead of substituting one common range.
Work through a five-report example
Imagine five fictional reports for “Marker Q”:
| Date | Reported result | Laboratory | Method note | Status |
|---|---|---|---|---|
| January | 8.0 qU/L | A | Method Alpha | Final |
| March | 8.4 qU/L | A | Method Alpha | Final |
| May | 8.1 qU/L | A | Method Alpha | Corrected from 81 qU/L |
| July | 0.79 qU/dL | B | Method Beta | Final |
| September | 0.82 qU/dL | B | Method Beta | Final |
The invented unit qU has no clinical meaning; it keeps the exercise free of a real decision threshold. Converting July and September from per deciliter to per liter yields 7.9 and 8.2 qU/L. The May preliminary-looking 81 should not remain as a biological spike because the final report corrects it to 8.1.
After unit alignment and report-status cleanup, the points look numerically similar. But Method Beta is still a method break. A responsible trend display marks it rather than drawing an unqualified continuous line through all five values.
The example shows three separate tasks: valid unit conversion, correction handling, and method comparability. Completing the first two does not automatically solve the third.
Keep corrected and cancelled reports visible in the audit
A corrected report should replace the earlier value in the active clinical series according to the health system's process, but the record of correction matters. Do not present the original as another specimen collected the same day. It was a different report state, not necessarily a second biological observation.
Likewise, cancelled, rejected, or unable-to-calculate results are not zeros. Leaving an empty space in a graph is more accurate than inserting a value the laboratory did not report. A delayed result should be placed at specimen collection time when that is the relevant biological date, with the report timing preserved separately if needed.
If a portal appears to retain both original and corrected values as equal points, use the exact final report and ask the responsible service how corrections are displayed. Do not choose whichever version makes the preferred trend.
Align collection context without pretending it is identical
Comparable methods do not remove biological and preanalytical variation. Record relevant preparation, collection time, illness, activity, and medicine context as directed for that test. The guide on why one lab value can shift explains these layers.
“Same conditions” is usually an approximation, not a guarantee. The body continues to vary. A carefully planned series reduces avoidable differences; it does not freeze physiology or eliminate measurement uncertainty.
Do not repeat testing or alter medicine, food, fluids, supplements, or activity to make a graph smoother unless the responsible healthcare professional gives those instructions. More frequent points can add variation and burden without improving the decision.
Normalize the display without normalizing the meaning
Once identity and valid conversions are established, use a table before a graph. A table can show units, laboratory, method break, and report status directly. If a graph is added, label the axis with the chosen unit and mark method changes or gaps.
Do not divide every result by the top of its reference interval and call the values clinically equivalent. That transformation can be useful for some analytic purposes, but reference intervals are not universal measurement scales. Their construction and relationship to decisions differ by test.
Similarly, a percent change can exaggerate movement near zero. Moving from 1 to 2 is a 100% increase and an absolute change of 1. Which description matters depends on the measurement's precision and clinical use.
Ask the laboratory a bounded question
When comparability matters, useful questions include: Did the method change? Are results from the named systems considered comparable for this purpose? Does a conversion apply to the exact analyte and specimen? Was the reference interval changed with the method? Is there a corrected final report?
NIST cautions that traceability alone does not prove a result is fit for a particular purpose. A laboratory can explain its method and reporting; the healthcare professional connects that information to the patient's clinical question.
Bring the reconciled series to the responsible professional with dates and context. The goal is not to perform a home calibration. It is to prevent unit, identity, and method changes from masquerading as biology before the trend is interpreted.
Sources reviewed 2026-09-03.
This general guide cannot establish whether two individual results are clinically comparable or interpret a trend.
Sources
- CDC: What is laboratory test standardization?
Standardization and harmonization aim to make selected laboratory measurements comparable across technologies, time, and location.
- CDC: Clinical Standardization Programs
CDC programs address accuracy and reliability for selected biomarkers; comparability is an active technical achievement rather than an assumption.
- NIST: Guide to the SI, Chapter 8
Units express defined quantities; concentration can be expressed in different forms that must not be treated as equivalent without a valid relationship.
- NIST: Metrological traceability FAQ
Traceability is a property of a measurement result supported by a documented chain of calibrations; it does not by itself establish fitness for a clinical purpose.